Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Atlanta, Georgia 30322


Purpose:

The majority of kidney stones are treated with shock wave lithotripsy (SWL). We are examining if the medication Flomax will result in improved stone passage rates following SWL.


Study summary:

Placebo blinded study examining the effects of Flomax on stone passage rates following SWL.


Criteria:

Inclusion Criteria: - urolithiasis undergoing SWL


NCT ID:

NCT00209131


Primary Contact:

Principal Investigator
Kenneth Ogan, MD
Emory University

Kenneth Ogan, MD
Phone: 404-778-3038
Email: kenneth_ogan@emoryhealthcare.org


Backup Contact:

N/A


Location Contact:

Atlanta, Georgia 30322
United States

Kenneth Ogan, MD
Phone: 404-778-3038
Email: kenneth_ogan@emoryhealthcare.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.